Human Heredity and Health in Africa (H3Africa): H3Africa Biorepository Grants (UH2/UH3)

The summary for the Human Heredity and Health in Africa (H3Africa): H3Africa Biorepository Grants (UH2/UH3) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Human Heredity and Health in Africa (H3Africa): H3Africa Biorepository Grants (UH2/UH3): This NIH Funding Opportunity Announcement (FOA), supported by funds from the NIH Common Fund (Common Fund) and participating NIH Institute(s) and Center(s), invites applications from foreign Institutions in African countries who wish to develop an H3Africa biorepository in order to provide an international site for the receipt, storage and distribution of samples from H3Africa research projects as well as other African genomic research studies. The NIH is partnering with the Wellcome Trust to provide support for H3Africa, an initiative to enhance the development of sustainable research capacity in Africa that will use genomics as a part of a cutting-edge approach to promote health and combat disease. The purpose of this FOA is to call for applications for UH2/UH3 cooperative agreements that will provide funding to develop plans, building upon existing infrastructure, for initial two-year feasibility studies (Phase I) and then for an additional five years of support forfull-scale H3Africa Biorepositories (Phase II), beginning in 2014. The outcome of the feasibility studies will be fully developed plans for up to 3 H3Africa Biorepositories, with evidence that the challenges enumerated below have been overcome.Feasibility testing/planning activities may include testing proposed logistical approaches, training, developing collaborations and otherwise building or planning for additional infrastructure that will be needed for a full-scale repository.
Federal Grant Title: Human Heredity and Health in Africa (H3Africa): H3Africa Biorepository Grants (UH2/UH3)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-12-003
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.172
CFDA Descriptions: Human Genome Research
Current Application Deadline: Feb 21, 2012
Original Application Deadline: Feb 21, 2012
Posted Date: December 21st, 2011
Creation Date: Dec 21, 2011
Archive Date: Mar 23, 2012
Total Program Funding: $400,000
Maximum Federal Grant Award: $115,000
Minimum Federal Grant Award:
Expected Number of Awards: 4
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); African institutions are eligible for the awards:
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Op...
Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult ...
Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com